Pfizer and KRIBB jointly to research for cancer drugs.

Pfizer and Korea Research Institute of Bioscience and Biotechnology (KRIBB) have made an MOU agreement for a joint research collaboration of the new therapeutic drugs in the area of liver and stomach cancer in the morning of June 14 in attendance of Chairman Jeff Kindler and other officers from the Pfizer head office.
The research included a drug discovery, preclinical studies and other nec...